Share This Page
Drug Price Trends for NDC 51645-0709
✉ Email this page to a colleague
Average Pharmacy Cost for 51645-0709
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ACETAMINOPHEN PM CAPLET | 51645-0709-05 | 0.04946 | EACH | 2024-12-18 |
| ACETAMINOPHEN PM CAPLET | 51645-0709-05 | 0.05519 | EACH | 2024-11-20 |
| ACETAMINOPHEN PM CAPLET | 51645-0709-05 | 0.04963 | EACH | 2024-10-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51645-0709
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
51645-0709 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 51645-0709
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a drug identified by the National Drug Code (NDC) 51645-0709, it is crucial to first understand what the NDC represents. The NDC is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code, each assigned by different entities. The labeler code is assigned by the FDA, while the product and package codes are assigned by the firm manufacturing or distributing the drug[1][5].
Drug Identification and Listing
The NDC 51645-0709 would be listed in the FDA's National Drug Code Directory, which contains information about finished drug products, including prescription and over-the-counter drugs, as well as compounded drug products. This directory is updated daily and includes data submitted by labelers in structured product labeling (SPL) electronic listing files[5].
Market Context
Global Pharmaceutical Market Trends
The pharmaceutical market is undergoing significant changes driven by digital transformation, innovation, and regulatory pressures. In 2025, life sciences executives are optimistic about the future, despite challenges such as pricing and access to drugs, competition from generics and biosimilars, and the patent cliff. The biopharma industry is facing substantial losses due to expiring patents, which could drive mergers and acquisitions[3].
Pricing and Access
Pricing and access to drugs are critical issues in the pharmaceutical industry. The U.S. market is characterized by higher drug prices compared to other regions. For instance, the average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is partly due to a drug mix that skews towards higher-cost drugs in the U.S.[4].
Specific Drug Analysis: NDC 51645-0709
Drug Details
To conduct a detailed analysis of the drug with NDC 51645-0709, one would need to identify the specific drug product, its labeler, and the product and package codes. Here is an example of how this might look:
- Labeler Code: The first segment of the NDC, which identifies the firm manufacturing or distributing the drug.
- Product Code: The second segment, which identifies the specific strength, dosage form, and formulation of the drug.
- Package Code: The third segment, which identifies the package size and type[1].
Price Trends
Price trends for a specific drug can be influenced by various factors, including market demand, competition, regulatory changes, and production costs. For example, the prices of Dapsone 5% Gel (NDC 51672-1387) have shown variations over time, with prices per unit changing based on the package size and date[2].
Market Analysis
Demand and Supply Dynamics
The demand for a drug with NDC 51645-0709 would depend on its therapeutic use, patient population, and competition within its therapeutic class. For instance, if the drug is used to treat a common condition, demand might be higher and more stable compared to a drug for a rare disease.
Competitive Landscape
The competitive landscape includes other drugs within the same therapeutic class, as well as generic or biosimilar alternatives. The entry of generics or biosimilars can significantly impact the pricing and market share of the original drug. For example, the biopharma industry is facing increased competition from generics and biosimilars, with 37% of executives viewing this as a top trend[3].
Price Projections
Historical Pricing Data
Analyzing historical pricing data for the drug can provide insights into future price trends. This involves looking at past price changes, market conditions, and any regulatory or competitive shifts that may have influenced pricing.
Market Forecasting
Market forecasting for pharmaceuticals often involves complex models that account for various factors such as:
- Regulatory Changes: Changes in regulatory policies can impact pricing and access.
- Competitive Dynamics: Entry of new drugs, generics, or biosimilars.
- Economic Factors: Inflation, healthcare spending trends.
- Technological Advancements: Impact of digital transformation and innovation on drug development and pricing[3].
Example of Price Projections
While specific data for NDC 51645-0709 is not provided, here is an illustrative example based on similar drugs:
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| Example Drug | 51645-0709 | 2.50 | GM | 2024-12-18 |
| Example Drug | 51645-0709 | 2.30 | GM | 2024-11-20 |
| Example Drug | 51645-0709 | 2.70 | GM | 2024-10-23 |
Based on historical data and market trends, if the drug faces increased competition from generics or biosimilars, the price might decrease. Conversely, if the drug remains a market leader with strong demand and no significant competition, prices might remain stable or increase slightly.
Key Takeaways
- NDC Understanding: The NDC is a critical identifier for drug products, consisting of labeler, product, and package codes.
- Market Trends: The pharmaceutical market is influenced by digital transformation, innovation, and regulatory pressures.
- Pricing Dynamics: Prices are affected by demand, competition, regulatory changes, and economic factors.
- Competitive Landscape: The entry of generics and biosimilars can significantly impact pricing and market share.
- Forecasting: Market forecasting involves complex models considering regulatory, competitive, economic, and technological factors.
FAQs
1. What does the National Drug Code (NDC) represent? The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package codes.
2. Why are some drug products not included in the NDC Directory? Drug products may not be included if they are not prescription, OTC, or insulin products, if the firm has notified the FDA that the product is no longer being marketed, or if the firm has not complied with listing obligations[1].
3. How do regulatory changes impact drug pricing? Regulatory changes can significantly impact drug pricing by affecting access, competition, and the overall market dynamics. For example, changes in approval processes or patent laws can influence pricing strategies[3].
4. What role do generics and biosimilars play in the pharmaceutical market? Generics and biosimilars play a crucial role by providing cheaper alternatives to branded drugs, thereby increasing competition and potentially reducing prices. This is a significant trend in the pharmaceutical industry, with 37% of executives viewing competition from generics and biosimilars as a top concern[3].
5. How does digital transformation affect the pharmaceutical industry? Digital transformation is expected to boost operational efficiencies and drive breakthrough innovations in the pharmaceutical industry. Technologies like gen AI and increased data use are anticipated to enhance R&D and improve patient outcomes[3].
Sources
- National Drug Code Database Background Information - FDA https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information
- Latest drug prices and trends for NDC 51672-1387 - DrugPatentWatch https://www.drugpatentwatch.com/p/drug-price/ndc/51672-1387
- 2025 life sciences outlook | Deloitte Insights https://www2.deloitte.com/us/en/insights/industry/health-care/life-sciences-and-health-care-industry-outlooks/2025-life-sciences-executive-outlook.html
- ISSUE BRIEF - ASPE https://aspe.hhs.gov/sites/default/files/documents/4326cc7fe43bc11770598cf2a13f478c/international-market-size-prices.pdf
- National Drug Code Directory - FDA https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
More… ↓
